Target intelligence / Profile preview

Pathogenic bacteria in the mouth

Molecular classification
Other
01

Overview

Pathogenic bacteria in the mouth refers to a diverse group of bacterial species present in dental plaque and oral biofilms that are capable of causing disease. Major examples include Streptococcus mutans (involved in dental caries), Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola (key pathogens in periodontitis, often called the “red complex”)[4][6][8]. These bacteria can form complex biofilms, evade host immune responses, and produce toxins and metabolic products that lead to tissue destruction, inflammation, and increased risk for systemic conditions[4][6][8]. Treatment typically involves antibiotics, antiseptics, improved oral hygiene, and sometimes specific antimicrobials targeting key pathogens[5][6][8][9]. Note: - There is no single canonical molecule, receptor, or gene corresponding to "Pathogenic bacteria in the mouth"; rather, the term encompasses hundreds of distinct bacterial species from multiple phyla (such as Firmicutes, Proteobacteria, Bacteroidetes, Actinobacteria, Spirochaetes)[2][9]. - For structured target information, individual species (e.g., Streptococcus mutans, Porphyromonas gingivalis) should be the entries rather than the broad "pathogenic bacteria in the mouth" category.

Other names
Oral pathogenic bacteriaoral pathogensdental pathogenspathogenic oral microbiota
02

Mechanism of action

Inhibition of cell wall synthesis (beta-lactam antibiotics), Inhibition of protein synthesis (tetracyclines, clindamycin), Inhibition of DNA synthesis (metronidazole), Disruption of cell membrane (antiseptics)

03

Biological functions

InfectionImmune evasionBiofilm formationTissue destructionOral colonization
04

Disease associations

InfectionInflammationPeriodontal diseaseDental cariesOral cancer (indirect association)Systemic disease (such as cardiovascular disease, diabetes, rheumatoid arthritis)Other
05

Safety considerations

Antibiotic resistanceDisruption of commensal oral floraRisk of systemic infection from oral pathogensAllergic reactions to antibiotics
06

Interacting drugs

Antibiotics (penicillin, amoxicillin, metronidazole, tetracycline, clindamycin)

2 more in the full profile.

07

Biomarkers

Presence of specific bacterial species (e.g., Porphyromonas gingivalis, Streptococcus mutans, Tannerella forsythia, Treponema denticola, Fusobacterium nucleatum)Dental plaqueDetection of bacterial DNA/RNA

Beyond the preview

Go deeper on Pathogenic bacteria in the mouth.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacteria in the mouth.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call